Skip to main content

Table 1 General characteristics of the studies and participants

From: Robotic-assisted versus laparoscopic colorectal surgery: a meta-analysis of four randomized controlled trials

Author

Year

Country

Group

N

Sex

BMI

ASA grade

Age, years

Disease

Tumor stage

Operation type

M/F

I/II/III/IV

I/ II/III/IV

Baik SH

2008

Korea

RCS

18

14/4

22.8 (1.8)

12/6/0/0

57.3 (6.3)

Rectal cancer

5/4/9/0

Tumor-specific mesorectal excision

LCS

18

14/4

24.0 (2.5)

9/6/1/1

62.0 (9.0)

5/4/9/0

Jimenez RR

2011

Spain

RCS

28

12/16

28.59 (2.5)

14/14a

68.0 (9.1)

Sigmoid colon cancer and rectal cancer

15/13b

Total or subtotal mesorectal excision

LC S

28

17/11

26.75 (5.6)

20/8a

61.5 (15.0)

21/7b

Park JS

2012

Korea

RCS

35

14/21

24.4 (2.5)

15/16/4/0

62.8 (10.5)

Right-sided colon carcinoma

10/16/9/0

Right colectomies

LCS

35

16/19

23.8 (2.7)

21/12/2/0

66.5 (11.4)

9/16/10/0

Patriti A

2009

Italy

RCS

29

11/18

24 (6.2)

2/13/14/0

68 (10)

Rectal cancer

11/9/7/2

Total mesorectal excision

LCS

37

12/25

25.4 (6.44)

2/14/21/0

69 (10)

17/8/10/2

  1. Values are expressed as mean (SD) or number. BMI, body mass index; ASA, American Society of Anesthesiologists; RCS, robotic-assisted colorectal surgery; LCS, laparoscopic colorectal surgery; M/F, male/female. a(I + II)/ III; b(T1 + T2)/T3.